[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drug Delivery Markets: Oral Delivery

July 2009 | 130 pages | ID: D2D2BD7E583EN
Kalorama Information

US$ 2,995.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral delivery drug market is a $35 billion industry and expected to grow as much as ten percent per year.

Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.

In the reporting of market size and growth through 2013, Kalorama’s unique analysis breaks out separates the value of the technology portion of the market from the active ingriedient portion of the market, allowing for a deeper understanding of the value of the market attributable to the delivery technologies themselves.

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
  • Legacy Companies in Oral Delivery as well as Recent Entrants
  • Current World Wide Revenue Across Product Categories and Future Forecasts
  • Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other)
  • Challenges Faced by Oral-Delivery Technology Companies
  • Success Stories and Pitfalls
  • The Trends That are Expected to Lead to Global Growth
Kalorama’s trusted information-gathering process provides most accurate study of the oral delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.
Chapter One: Executive Summary

Market Drivers
Market Size and Growth
Total Oral Drug Delivery Market
Oral Drug Delivery Technology Only Market
Competitive and Market Analysis

Chapter Two: Introduction and Overview

Scope of the Report
Methodology
History of Oral Drug Delivery
Phases of Drug Action
Barriers to Oral Drug Delivery
Controlled-Release/Sustained-Release
Delayed Release and Modified Release
Fast Dissolving
Taste-Masked
Pulsatile Release
Microemulsion and Others

Chapter Three: Key Trends and Demographics

The Elderly
Regulatory Environment
Patent Protection and Extension
Earlier Involvement
Consolidation
Proprietary Product Development
Implications for Generic and Over-the-Counter Products
Pharmaceutical Formulation

Chapter Four: New Developments

Macromolecule Delivery
Delivery of Hydrophobic Drugs
Other Delivery Solutions

Chapter Five: Market Size and Growth

The Total Oral Drug Delivery Market
Oral Delivery Technology Only Market

Chapter Six: Competitive Analysis

Competitive Landscape

Chapter Seven: Company Profiles

ALZA Corporation
Biovail Corporation
Elan Corporation, plc
Emisphere Technologies, Inc.
Ethypharm
KV Pharmaceutical
Labopharm, Inc.
Penwest Pharmaceutical Company
Purdue/MundiPharma/Napp Group
SkyePharma PLC
Watson Pharmaceuticals, Inc.

Chapter Eight: Companies in Brief

Alkermes, Inc.
Astellas Pharma US
CIMA Labs, Inc. Division of Cephalon
DepoMed, Inc.
Eurand, Inc.
Galenix
Intelgenx Technologies Corp
Kos Pharmaceuticals, Inc.
Lifecycle Pharma
MicroDose Therapeutics, Inc.
Scolr Pharma
Xcelience

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

Chapter Two: Introduction and Overview

Table 2-1: Selected Types of Oral Solid Preparations
Table 2-2: Sequence of Drug Action

Chapter Three: Key Trends and Demographics

Table 3-1: World Population by Age Group 2006-2013
Figure 3-1: World Population by Age Group 2006-2013
Table 3-2: Recent Consolidations in the Drug Delivery Market

Chapter Four: New Developments

Chapter Five: Market Size and Growth

Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2006-2013
Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2006-2013
Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013
Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013
Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2006-2013
Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2006-2013
Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Delivery Technology Components 2006-2013
Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical vs. Delivery Technology Component 2006, 2010

Chapter Six: Competitive Analysis

Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)


More Publications